Genotype-Tissue Expression Project

Genotype-Tissue Expression Project
Name	Genotype-Tissue Expression Project
Acronym	GTEx
Established	2010
Country	United States
Coordinating agency	National Institutes of Health, National Human Genome Research Institute, National Institute of Mental Health

Contents

Genotype-Tissue Expression Project The Genotype-Tissue Expression Project was a large-scale biomedical research initiative that mapped human gene expression across multiple tissues to connect genetic variation with transcriptional regulation. Funded by National Institutes of Health, coordinated by institutes including National Human Genome Research Institute and National Institute of Mental Health, the project provided a resource for researchers in fields such as oncology, neuroscience, cardiology, immunology and pharmacogenomics. The dataset has been used by consortia and institutions like Broad Institute, Stanford University, Harvard University, University of California, San Francisco and University of Chicago.

Overview

The project generated paired genotype and tissue-specific transcriptomic profiles from hundreds of donors to identify expression quantitative trait loci (eQTLs), splicing QTLs and regulatory variants across tissues, enabling mechanistic interpretation of signals from studies by groups such as International HapMap Project, 1000 Genomes Project, ENCODE Project, Roadmap Epigenomics Project and the Cancer Genome Atlas. Analysts from centers like Wellcome Trust Sanger Institute, European Molecular Biology Laboratory, Van Andel Institute and Cold Spring Harbor Laboratory integrated GTEx findings with resources from NHGRI, National Cancer Institute, National Heart, Lung, and Blood Institute and pharmaceutical partners including Pfizer, Novartis, Roche.

Launched in 2010 under programs administered by National Institutes of Health, the initiative involved collaborations among academic medical centers such as Johns Hopkins University, Yale University, Columbia University, University of Pennsylvania and biobanks like UK Biobank and regional organ procurement organizations. Leadership and advisory contributions came from investigators affiliated with Massachusetts Institute of Technology, University of California, Los Angeles, Duke University, Michigan Medicine and nonprofit stakeholders including Howard Hughes Medical Institute and Wellcome Trust. The governance model reflected practices from projects like Human Genome Project and included data access committees similar to those used by dbGaP and European Genome-phenome Archive.

GTEx collected biospecimens from postmortem donors, obtaining RNA-seq, whole-genome genotypes and metadata processed by core labs at centers such as Broad Institute, Illumina and Thermo Fisher Scientific. Quality control pipelines incorporated tools developed at EMBL-EBI, European Bioinformatics Institute, National Center for Biotechnology Information and groups led by investigators from Cold Spring Harbor Laboratory and Salk Institute. Analyses used statistical frameworks from teams at Stanford University, Massachusetts Institute of Technology, University of Oxford, University of Cambridge and applied methods popularized by consortia like GTEx Consortium members affiliated with Yale School of Medicine and UCLA Medical Center.

Results revealed tissue-specific and shared regulatory variants, providing mechanistic context for genome-wide association study signals identified in cohorts such as Framingham Heart Study, UK Biobank, Nurses' Health Study and disease-focused consortia in Alzheimer's disease, Parkinson's disease, type 2 diabetes and coronary artery disease. Work informed functional interpretation efforts at Broad Institute, supported drug target validation at companies like Amgen and AstraZeneca, and influenced guideline development at institutions including Food and Drug Administration and European Medicines Agency. Key publications involved collaborative authors from Harvard Medical School, Yale School of Medicine, Mount Sinai Health System, Icahn School of Medicine at Mount Sinai and University of Michigan.

GTEx released genotype and expression data to controlled-access repositories patterned after dbGaP and institutional archives maintained by National Institutes of Health, with summary statistics shared through portals similar to those at Ensembl, UCSC Genome Browser, GENCODE and Gene Expression Omnibus. Tooling and visualization were developed by teams at Broad Institute, Stanford University, University of California, Santa Cruz and third-party resources like LocusZoom, GTEx Portal collaborators, and bioinformatics groups at European Bioinformatics Institute and Wellcome Sanger Institute.

Critiques highlighted donor representation biases compared with population cohorts such as 1000 Genomes Project and UK Biobank, limitations in sample sizes for rare variant analysis analogous to challenges faced by ENCODE Project and constraints in tissue preservation similar to debates in postmortem studies at Harvard Medical School and Columbia University. Ethical and consent discussions involved stakeholders including National Institutes of Health, institutional review boards at Johns Hopkins University, Yale University and patient advocacy organizations like Alzheimer's Association and American Heart Association, with calls for improved diversity and integration with clinical cohorts such as All of Us Research Program.